1. Home
  2. BLX vs WVE Comparison

BLX vs WVE Comparison

Compare BLX & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banco Latinoamericano de Comercio Exterior S.A.

BLX

Banco Latinoamericano de Comercio Exterior S.A.

HOLD

Current Price

$53.77

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.51

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLX
WVE
Founded
1977
2012
Country
Panama
Singapore
Employees
372
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.4B
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
BLX
WVE
Price
$53.77
$6.51
Analyst Decision
Strong Buy
Analyst Count
0
16
Target Price
N/A
$29.81
AVG Volume (30 Days)
119.3K
3.9M
Earning Date
04-27-2026
04-28-2026
Dividend Yield
5.13%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,704,000.00
Revenue This Year
$18.36
N/A
Revenue Next Year
$9.95
$85.67
P/E Ratio
$8.26
N/A
Revenue Growth
N/A
149.43
52 Week Low
$38.41
$5.02
52 Week High
$57.79
$21.73

Technical Indicators

Market Signals
Indicator
BLX
WVE
Relative Strength Index (RSI) 50.54 33.83
Support Level $52.31 $5.02
Resistance Level $55.30 $7.65
Average True Range (ATR) 1.34 0.37
MACD -0.25 0.06
Stochastic Oscillator 51.65 24.40

Price Performance

Historical Comparison
BLX
WVE

About BLX Banco Latinoamericano de Comercio Exterior S.A.

Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration. The Bank provides foreign trade solutions to a select client base of American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments: the Commercial Business Segment and the Treasury Business Segment. The majority of its revenue is generated from the Commercial Business segment.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: